Cedar Wealth Management’s Biogen BIIB Stock Holding History

Cedar Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-897	Closed	-$239K	–	305
2022 Q3	$239K	Hold	897	–	–	0.12%	92
2022 Q2	$183K	Hold	897	–	–	0.08%	110
2022 Q1	$189K	Hold	897	–	–	0.08%	118
2021 Q4	$215K	Hold	897	–	–	0.09%	120
2021 Q3	$254K	Hold	897	–	–	0.11%	98
2021 Q2	$311K	Buy	897 +361	+67%	+$109K	0.14%	87
2021 Q1	$150K	Buy	+536	New	+$145K	0.07%	109

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cedar Wealth Management's BIIB Position: Q4 2022 in Review

Cedar Wealth Management sold out of Biogen (BIIB) in Q4 2022, closing a stake of 897 shares — an estimated $239K sold.

Cedar Wealth Management first reported a position in BIIB in Q1 2021 and held it in 7 quarters. The position peaked at $311K in Q2 2021. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Cedar Wealth Management reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Cedar Wealth Management sold 897 Biogen shares in Q4 2022, an estimated $239K.
Cedar Wealth Management first reported a position in Biogen in Q1 2021 and held it in 7 quarters.
Cedar Wealth Management's Biogen position peaked at $311K in Q2 2021.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Cedar Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.